Second thoughts about kava [2]

American Journal of Medicine

Volumn 113, Issue 4, 2002, Pages 347-348

  Ernst, Edzard ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; HISTAMINE RECEPTOR; KAVA; KAVA EXTRACT; PYRONE DERIVATIVE;

ANXIETY DISORDER; CLINICAL TRIAL; CYSTITIS; DIET SUPPLEMENTATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; GONORRHEA; HUMAN; LETTER; LIVER TOXICITY; MUSCLE RELAXATION; PARKINSONISM; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SELF MEDICATION; SLEEP INDUCTION; SYPHILIS; TRANQUILIZING ACTIVITY; WEIGHT REDUCTION;

EID: 0036701598     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(02)01204-4     Document Type: Letter

References (9)

1. Ernst E., Pittler M.H., Stevinson C., et al. The Desktop Guide to Complementary and Alternative Medicine. 2001;128-130 Mosby, Edinburgh, UK.
2. Blumenthal M., Goldberg A., Brinckmann J., Herbal Medicine Expanded Commission E Monographs . 2000;221-225 Integrative Medicine Communications, Austin, TX.
3. Pittler M.H., Ernst E. Efficacy of kava extract for treating anxiety systematic review and meta-analysis . J Clin Psychopharmacol. 20:2000;84-89.
4. Dinh L.D., Simmen U., Bueter K.B., et al. Interaction of various Piper methysticum cultivars with CNS receptors in vitro. Planta Med. 67:2001;306-311.
5. Gruenwald J., Freder J. Kava the present European situation . Nutraceuticals World. January/February:2002;22-24.
6. Blumenthal M. Herbal market levels after five years of boom. Herbal Gram. 47:1999;64-65.
7. Gruenwald J. International kava-alliance. Neutraceuticals World. April:2002;22-23.
8. Loew D.L. Kava kava extrakt. Dtsche Apotheker Zeitung. 141:2002;64-74.
9. Meseguer E., Taboada R., Sánchez V., et al. Life-threatening parkinsonism induced by Kava-Kava. Mov Disord. 17:2002;195-196.